Supreme Court Rejects Teva's Reglan Preemption Dispute
The U.S. Supreme Court on Monday rejected Teva Pharmaceuticals USA Inc.'s request to review a Pennsylvania appellate ruling that federal law did not preempt the product liability claims of thousands of...To view the full article, register now.
Already a subscriber? Click here to view full article